Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maes

Showing results (161-170 of 323) with videos related to

Pageof 33
Sort By:
Clinical Pharmacokinetics|August 19, 1999
Intravesical drug delivery. Pharmacokinetic and clinical considerationsM S Highley, A T van Oosterom, R A Maes, et al.
European Journal of Pharmacology|July 4, 1995
The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effectsL Groenink, J Van der Gugten, P M Verdouw, et al.
The European Journal of Neuroscience|November 1, 1996
5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamusJ C Compaan, L Groenink, J van der Gugten, et al.
Nuklearmedizin. Nuclear Medicine|February 18, 2010
Impact of FDG PET on the management of TBC treatment. A pilot studyM Sathekge, A Maes, M Kgomo, et al.
Biological Mass Spectrometry|August 1, 1991
The analysis of trenbolone and the human urinary metabolites of trenbolone acetate by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometryD de Boer, M E Gainza Bernal, R D van Ooyen, et al.
European Journal of Pharmacology|April 18, 1997
Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamusJ C Compaan, L Groenink, J Van der Gugten, et al.
Acta Oto-Laryngologica. Supplementum|January 1, 1986
The use of a SQUID magnetometer in the study and development of normal and artificial middle earW L Rutten, D Bakker, J H Kuit, et al.
Journal of Nuclear Medicine Technology|October 2, 1998
Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusionH Everaert, A Maes, A S Hambye, et al.
The Annals of Thoracic Surgery|January 22, 1998
PET scan predicts recovery of left ventricular function after coronary artery bypass operationW J Flameng, B Shivalkar, B Spiessens, et al.
Arzneimittel-Forschung|January 1, 1982
Pharmacokinetics of terbutaline, a beta 2-sympathomimetic, in healthy volunteers and asthmatic patientsJ G Leferink, W van den Berg, I Wagemaker-Engels, et al.
Pageof 33

Showing results (161-170 of 323) with videos related to

Sort By:
Pageof 33
Clinical Pharmacokinetics|August 19, 1999
Intravesical drug delivery. Pharmacokinetic and clinical considerationsM S Highley, A T van Oosterom, R A Maes, et al.
European Journal of Pharmacology|July 4, 1995
The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effectsL Groenink, J Van der Gugten, P M Verdouw, et al.
The European Journal of Neuroscience|November 1, 1996
5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamusJ C Compaan, L Groenink, J van der Gugten, et al.
Nuklearmedizin. Nuclear Medicine|February 18, 2010
Impact of FDG PET on the management of TBC treatment. A pilot studyM Sathekge, A Maes, M Kgomo, et al.
Biological Mass Spectrometry|August 1, 1991
The analysis of trenbolone and the human urinary metabolites of trenbolone acetate by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometryD de Boer, M E Gainza Bernal, R D van Ooyen, et al.
European Journal of Pharmacology|April 18, 1997
Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamusJ C Compaan, L Groenink, J Van der Gugten, et al.
Acta Oto-Laryngologica. Supplementum|January 1, 1986
The use of a SQUID magnetometer in the study and development of normal and artificial middle earW L Rutten, D Bakker, J H Kuit, et al.
Journal of Nuclear Medicine Technology|October 2, 1998
Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusionH Everaert, A Maes, A S Hambye, et al.
The Annals of Thoracic Surgery|January 22, 1998
PET scan predicts recovery of left ventricular function after coronary artery bypass operationW J Flameng, B Shivalkar, B Spiessens, et al.
Arzneimittel-Forschung|January 1, 1982
Pharmacokinetics of terbutaline, a beta 2-sympathomimetic, in healthy volunteers and asthmatic patientsJ G Leferink, W van den Berg, I Wagemaker-Engels, et al.
Pageof 33